Skip to main content
TipRanks
Go Ultimate75% OFF

dorsaVi Limited (DVL) AI Stock Analysis

9 Followers
AU:DVL

dorsaVi Limited

(ASX:DVL)

Select Model
Rating:40Underperform
Price Target:AUD 0.02â–¼(-5.00% Downside)
Action:downgraded
Date:09/15/26

The overall score of 40 reflects a company in severe financial distress, which is the most significant factor. The business is unprofitable with a collapsed gross margin and is burning cash at an accelerating, unsustainable rate. This fundamental weakness is confirmed by a bearish technical trend, with the stock trading below key moving averages and showing negative momentum. The negative P/E ratio further underscores the lack of earnings power. The only minor mitigating factor is a low-debt balance sheet, but it is being rapidly consumed by operating losses.

Positive Factors
Low Balance-Sheet LeverageVery low leverage gives dorsaVi greater financial resilience than its earnings profile alone would suggest. Lower debt and interest obligations preserve flexibility to fund operations, manage volatility, or pursue product development without the same refinancing pressure faced by a highly leveraged company.
Negative Factors
Persistent UnprofitabilityOngoing losses indicate that current revenue scale has not yet supported a sustainable cost structure. The sharply larger 2026 net loss raises concern that operating leverage remains weak, limiting internally generated funding and increasing the challenge of converting product adoption into durable shareholder returns.

dorsaVi Limited (DVL) vs. iShares MSCI Australia ETF (EWA)

-60%-40%-20%0%20%40%AU:DVL-48.72%EWA+13.03%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
AUD 26.05M
Dividend Yield
―
Average Volume (3M)
689.86K
Price to Earnings (P/E)
-2.6
Beta (1Y)
1.80
Revenue Growth
-11.13%
EPS Growth
-280.00%
Country
Australia
Employees
34
Sector
Technology
Sector Strength
61
Industry
Hardware, Equipment & Parts

dorsaVi Limited Business Overview & Revenue Model

Company Description

dorsaVi Ltd, an Australian company established in 2008 and based in Oakleigh South, focuses on creating and distributing advanced motion analysis technologies throughout Australia, Europe, and the United States. Its product portfolio includes ViMove+...

dorsaVi Limited Financial Statement Overview

Summary

Financial performance is critically weak. The Income Statement (Score 8) shows collapsing revenue and a deeply negative gross margin, while Cash Flow (Score 5) reveals an accelerating, unsustainable cash burn. The Balance Sheet (Score 55) offers a slight buffer with low debt, but equity is being rapidly eroded by massive losses. The overall picture is one of severe financial distress.

Income Statement

8Very Negative

Balance Sheet

55Neutral

Cash Flow

5Very Negative
Financial statement breakdown
BreakdownTTMJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue1.00M1.00M1.13M1.30M1.75M2.35M
Gross Profit-3.33M-3.33M971.82K1.18M-798.43K-1.45M
EBITDA-7.36M-7.36M-1.82M-1.60M-1.88M-1.53M
Net Income-8.52M-8.52M-1.52M-1.25M-1.82M-1.54M
Balance Sheet
Total Assets5.85M5.85M3.97M2.18M2.69M3.36M
Cash, Cash Equivalents and Short-Term Investments2.12M2.12M2.29M478.10K878.72K449.70K
Total Debt68.25K68.25K156.89K190.17K321.85K1.18M
Total Liabilities1.51M1.51M1.14M1.16M1.01M2.13M
Stockholders Equity4.34M4.34M2.84M1.02M1.68M1.22M
Cash Flow
Free Cash Flow-5.28M-5.28M-956.83K-622.08K-1.02M-2.25M
Operating Cash Flow-5.28M-5.28M-956.83K-600.90K-967.41K-2.15M
Investing Cash Flow-5,638-5,638-304.00K-21.18K-51.65K-100.34K
Financing Cash Flow5.12M5.12M3.08M227.06K1.45M-92.25K

dorsaVi Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price0.02

Price Trends

50DMA0.02Negative
100DMA0.02Negative
200DMA0.03Negative

Market Momentum

MACD-0.00Negative
RSI44.91Neutral
STOCH50.00Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DVL, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.03, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 44.91 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:DVL.

dorsaVi Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

AU:DVL against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *61Neutral$37.18B12.37-10.20%1.83%8.50%-7.62%
AU:CATAU:CAT60NeutralAUD 893.61M-9.25-29.78%―14.06%-195.34%
AU:X2MAU:X2M45NeutralAUD 8.70M-0.59136.97%―38.17%83.44%
AU:VR1AU:VR142NeutralAUD 33.09M-3.78-23.77%―10.62%36.67%
AU:DVLAU:DVL40UnderperformAUD 27.42M-2.63-165.14%―-11.13%-280.00%
AU:AUAAU:AUA39UnderperformAUD 4.48M-3.06-247.44%―17.51%43.31%
AU:NVUAU:NVU38UnderperformAUD 50.02M-3.62-92.06%―――

* Technology Sector Average

Performance Comparison

0%100%200%300%AU:DVLAU:CATAU:X2MAU:VR1AU:AUAAU:NVUDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AU:DVL and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
AU:DVLdorsaVi Limited0.02-0.02-50.00%
AU:CATCatapult Group International Ltd.2.89-1.62-35.92%
AU:X2MX2M Connect Limited0.010.0020.00%
AU:VR1Vection Technologies Ltd.0.01-0.02-60.00%
AU:AUAAudeara Ltd.0.02-0.01-18.52%
AU:NVUNanoveu Ltd.0.05-0.03-36.99%

dorsaVi Limited Corporate Events

dorsaVi Signs LuxingSport as First French Distributor

Nov 18, 2026

dorsaVi has signed a distribution agreement with France-based LuxingSport, its first French distributor, to promote its wearable sensing and Video AI movement-analysis products through established channels serving elite sport, physiotherapy and resea...

DorsaVi Sets 2026 AGM to Confirm Board, Auditor and Capital Raising

Oct 30, 2026

DorsaVi Ltd, a Melbourne-based wearable sensor and motion analysis specialist, serves healthcare, workplace safety, and sports performance markets with technology that measures and analyses human movement. The company leverages its data-driven biomec...

DorsaVi Clears Trading for 135.9 Million New Shares with Section 708A Notice

Oct 23, 2026

DorsaVi has issued 131,818,181 fully paid ordinary shares in line with its earlier capital raising announcement, along with 4,090,909 shares to settle placement fees, bringing the total new share issuance to 135,909,090. The company has lodged a Sect...

DorsaVi Issues New Tranche of Unlisted Long-Dated Options

Oct 23, 2026

DorsaVi Ltd has notified the market of a new issue of 2,045,455 unquoted options, exercisable at $0.045 and expiring on 23 October 2029, under its latest Appendix 3G filing with the ASX. The options issuance, dated 23 October 2026, modestly expands t...

DorsaVi Issues 65.9 Million Unquoted Options in Capital Management Move

Oct 23, 2026

DorsaVi Ltd has notified the market of the issue of 65,909,090 unquoted options, exercisable at $0.045 and expiring on October 23, 2029. The options form part of previously announced transactions and are not intended to be quoted on the ASX, indicati...

dorsaVi Seeks ASX Quotation for 131.8 Million New Shares

Oct 23, 2026

dorsaVi Ltd has applied to the ASX for quotation of 131,818,181 new ordinary fully paid shares under code DVL, with an issue date of 23 October 2026. The large volume of new securities, issued pursuant to a previously announced transaction, points to...

dorsaVi launches Sensor v6.5 as RRAM chip fabrication advances

Oct 22, 2026

dorsaVi commercially launched Sensor v6.5, its first wearable device that can measure movement, analyse patterns linked to injury risk, decide on appropriate responses and deliver configurable haptic, audible or visual biofeedback directly on-sensor...

dorsaVi sets November date for AGM as it advances ultra-edge strategy

Oct 12, 2026

dorsaVi Ltd has scheduled its 2026 Annual General Meeting for 30 November 2026, with a 19 October 2026 deadline for shareholders or other parties to nominate candidates for election to the board. The meeting timetable underscores standard governance...

dorsaVi Plans Major Equity Issue to Boost Capital Base

Oct 5, 2026

dorsaVi Ltd has outlined plans for a new capital raise via a proposed issue of securities on the ASX, including up to 136,363,636 fully paid ordinary shares and 68,181,818 unlisted options exercisable at $0.045, expiring three years from the issue da...

DorsaVi Plans Issue of 24 Million Unlisted Options on ASX

Oct 5, 2026

DorsaVi Ltd has notified the ASX of a proposed issue of securities in the form of 24 million unlisted options, exercisable at $0.045 and expiring three years from the date of issue. The options, to be issued on 19 October 2026, will be created as a n...

DorsaVi Raises A$3 Million to Accelerate Physical AI and Humanoid Robotics Strategy

Oct 5, 2026

DorsaVi Limited has secured firm commitments to raise A$3 million via a placement to high-net-worth and other sophisticated investors, issuing new shares at A$0.022 each to bolster its strategic shift toward Physical AI and advanced robotics. The fun...

dorsaVi Seeks Trading Halt Ahead of Proposed Capital Raising

Oct 1, 2026

dorsaVi Limited, an ASX-listed company based in Perth and trading under the ticker DVL, operates in the public capital markets and uses equity raisings as part of its funding strategy. Although the release does not elaborate on its specific products...

dorsaVi pivots movement data and neuromorphic tech toward humanoid robotics

Sep 20, 2026

dorsaVi Limited is leveraging its long-established movement data library, wearable sensors and Video AI capabilities, which span clinical, workplace, sporting and animal applications, to move beyond its traditional sensor markets. The company also ho...

dorsaVi Advances Energy-Efficient RRAM for Physical AI and Robotics

Sep 13, 2026

dorsaVi Limited has begun specialised electrical measurements to characterise the energy required to update states in its engineered resistive random-access memory structures, a crucial metric for its low-power RRAM-CMOS hardware roadmap. The device-...

DorsaVi widens annual loss but boosts net assets through capital raisings and new licences

Aug 31, 2026

DorsaVi Limited reported a 5.8% increase in revenue to $1.59 million for the year ended 30 June 2026, but its loss after tax surged to $8.52 million, more than five times the prior year, with no dividends declared. Despite the deeper loss and an audi...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 15, 2026